LASERS IN SURGERY AND MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2022-07-05 oniion123

这本杂志今年是踢出SCI了么，查不到影响因子啊

58 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2022-07-26 975473751

under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……

57 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2022-06-30 小胖子罗军

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：光动力
经验分享：哥你21年的影响因子怎么没了。。。。

52 0

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2020-10-23 147f5779m15(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：血管方向
经验分享：2020.2.18 提交
2020.4.25大修
2020.6.30修回
2020.7.24小修
2020.8.30第二次小修
2020.10.8第三次小修
2020.10.15 Accepted
好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！

182 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2021-12-29 MS68862005

俢回包括几个方面？

75 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

俢回的流程是什么？

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2021-11-02 fanyanyingwei

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：光学成像;激光医学
经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。

89 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2020-07-01 伊森

审稿速度:2.0 | 投稿命中率:75.0
经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice

165 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2020-04-07 荼蘼在半夏

审稿速度:2.0 | 投稿命中率:50.0
经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了

182 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230735, encodeId=c90a1230e35fa, content=这本杂志今年是踢出SCI了么，查不到影响因子啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c91d2182239, createdName=oniion123, createdTime=Tue Jul 05 18:29:57 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234947, encodeId=f5dd123494e08, content=under review 3个多月了，给编辑发邮件也没回，不知道怎么回事……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1d4787481, createdName=975473751, createdTime=Tue Jul 26 21:44:36 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229783, encodeId=b3e41229e831a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：光动力 经验分享：哥你21年的影响因子怎么没了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jun 30 20:45:41 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893944, encodeId=4fc689394403, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血管方向 经验分享：2020.2.18 提交 2020.4.25大修 2020.6.30修回 2020.7.24小修 2020.8.30第二次小修 2020.10.8第三次小修 2020.10.15 Accepted 好艰辛的投稿历程，但是主编是真的好，每篇邮件都会回复，很好沟通，貌似是中国人。这个文章在中科院最新升级版已经位列皮肤科1区，赶紧投。主要是主编真的好！真的好！真的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Fri Oct 23 13:43:14 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094661, encodeId=8b011094661d2, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094662, encodeId=395e1094662d9, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066349, encodeId=96b01066349e2, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：光学成像;激光医学 经验分享：该杂志审稿免费，一审周期比较快，差不多一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8eb1607761, createdName=fanyanyingwei, createdTime=Tue Nov 02 20:25:21 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800716, encodeId=48e8800e1656, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：4.7投稿，5.15一审意见修回给大修，6.9修回，6.17接收，整体来说审稿专家和编辑都很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/4470716f65d84279acca833c9c9e583a/0a2ae216566345f19f6aabb6d61fd694.jpg, createdBy=73771740647, createdName=伊森, createdTime=Wed Jul 01 07:35:06 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588371, encodeId=6bbf5883e10c, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：19年投过一次光动力的论文，9月13日投稿，10月26日返修（大修），之后又经过了两次小修，12月26日接收，整体来说速度很高效，最后一次小修后隔了一天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNwiakbojuicPkqfyGCuGYMqdjVzSZ8Bn9l7Z3ak7iaTCWrVNcmtKMfKWkIXDPibOdWZeohDUbg0RK412fgia8nvt8w/132, createdBy=98252334594, createdName=荼蘼在半夏, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588877, encodeId=a2d95888e794, content=2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a9e5257512, createdName=147f5779m15(暂无昵称), createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=)]

2020-04-15 147f5779m15(暂无昵称)

2020-2-13投稿，现在还在under review，可能由于疫情的影响，杂志流程变慢吧。

184 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务